Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnston Press PLC Share News (JPR)

  • There is currently no data for JPR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker tips: Johnston Press, Direct Line, Hikma Pharmaceuticals

Thu, 04th Aug 2016 11:01

(ShareCast News) - Johnston Press shares plunged on Thursday as Numis placed its rating and target price 'under review' after the company swung to a first half loss.For the 26 weeks to 2 July, the company posted a statutory pre-tax loss of £183.7m versus a £2.2m profit the year before, as it booked a £183.6m non-cash impairment reflecting a change of assumptions on its publishing titles and print assets.Advertising revenues were down 17.9% in the first quarter but improved marginally, with a 15% drop in the second quarter despite the impact of the run-up to and uncertainty following the UK's vote to leave the European Union in June.Chief executive Ashley Highfield said the market continues to be challenging and uncertainty surrounding the outcome of the Brexit negotiations has caused further softness in some segments of the advertising market, in June and July.Numis said the half year results came in below its estimates at every level."Our key issue at Johnston remains debt which has risen to £209m (from £179.4m) representing almost 4x our annualised EBITDA."This material debt pile, relative to cashflows, in combination with the declining and uncertain trading environment place a significant question mark on the equity value in the business."Numis said it expects to cut estimates "reasonably sharply" in both fiscal years 2016 and 2017. Direct Line Insurance Group's rating has been downgraded to 'hold' from 'buy' by Berenberg as the broker said "questions remain about earnings sustainability"."We believe there is some risk regarding the sustainability of Direct Line's earnings," Berenberg said in a note on Wednesday."High reserve releases, lower than forecast cost savings and a shrinking direct market all cast doubt on future earnings."Berenberg said older accident years have been incredibly profitable for Direct Line but these years are now contributing increasingly less releases.The broker said it does not expect to see the same developments in more recent accident years. Berenberg believes it will be difficult for management to offset falling reserve releases with the current accident year and operating improvements."As reserve releases decline, we expect earnings to be flat at best, thus we believe it will be challenging to grow the dividend from here," the broker said.Berenberg reiterated a target price of 406p.Direct Line on Tuesday posted its half year report for the six months to 30 June on Tuesday. Operating profit fell 5% to £316.9m, hurt by lower investment gains and the new Flood Re levy, but the group beat its own consensus estimates of £263m. Analysts at Citi downgraded their recommendation on shares of Hikma Pharmaceuticals in the wake of the company´s trading update which was issued after the close of trading in London on 3 August.Hikma flagged new drug approvals were arriving more slowly than expected and the phasing of litigation costs at US generics.On the basis of the above, the broker´s analysts lowered their recommendation on the shares from 'buy' to 'neutral' and set a target price of 2,600p.They also lowered estimates for the drugmaker´s core 2016 earnings before interest and taxes and earnings per share by 9.0% to $367m and $1.08, respectively - below the equivalent figures of $420m and $1.22 expected by the consensus.EPS estimates from 2017 onwards were cut by between 2% and 5% from 2017 onwards, with rates in foreign exchange markets expected to be an "incremental headwind".What was Citi´s view? "Developments at US Generics at best can be described as a 'short term hiccup'. At worse, sentiment concerns around the revenue/margin potential from the Roxane pipeline will increase, which is not helped by the lack of clarity on the pipeline given commercial sensitivities until 2017."If one were to cut his Roxane pipeline estimates by half, that would lead to EPS downgrades of between -15.0% and -20.0%, Citi said.Citi estimated the company´s net present value (NPV) at 2,900p, with a weighted average cost of capital of 8.0%, a terminal growth value (the rate at which free cash flows are expected to grow for eternity) of 2.0% and cable´s exchange rate at 1.32.
More News
13 Nov 2013 09:46

Johnston Press Expects Full-Year Operating Profit At Mid-Range Of Expectations

Read more
22 Oct 2013 17:11

DIRECTOR DEALINGS: Johnston Press Executive Buys 944 Shares

Read more
7 Oct 2013 15:14

DIRECTOR DEALINGS: Johnston Press CEO, Managers Granted Shares Under Sharesave Plan

Read more
24 Sep 2013 10:47

DIRECTOR DEALINGS: Johnston Press Director Buys Shares

Read more
19 Sep 2013 12:50

DIRECTOR DEALINGS - Non-Exec Directors Purchase Shares

Read more
28 Aug 2013 10:01

Johnston Press reports decline in first half revenue

Media group Johnston Press reported a 9.8 per cent fall in like-for-like total revenue at 144.3m pounds in the first half as advertising sales slipped. A 13.6% drop in advertising revenue failed to offset a 13.3% increase in digital revenue. Nevertheless, the company managed to achieve a 4.3% ris

Read more
15 May 2013 09:53

Johnston Press names new Chief Financial Officer

Community media group Johnston Press has reported that from June 1st 2013 David King will succeed Grant Murray, following Grant's resignation as Chief Financial Officer. King was previously at Time Out Group, the print and digital entertainment information business, where he was Chief Executive Off

Read more
14 May 2013 08:04

Tuesday broker round-up UPDATE

Babcock International: Jefferies increases target price from 1080p to 1250p and maintains a buy recommendation. Barratt Developments: Bank of America takes target price from 265p to 325p, while downgrading to neutral. Belgravium Technologies: WH Ireland places both its target price and its neutral

Read more
13 May 2013 10:21

STOCKS NEWS EUROPE-UK small caps edge lower, outperform FTSE

The FTSE small cap index is down 0.1 percent, outperforming a 0.4-percent weaker FTSE mid-caps and a 0.3-percent fall for the FTSE blue chip index. Johnston Press falls 7.9 percent after the company said its total revenues fell 11.4 percent in the 18 weeks to May 4 on a like-for-like basis

Read more
22 Mar 2013 08:48

Friday broker round-up UPDATE

Afren: Nomura shifts target price from 175p to 180p keeping a neutral rating. ASOS: Nomura increases target price from 2000p to 2630p, while reiterating a neutral rating. Betfair: Panmure Gordon takes target price from 761p to 813p and leaves its buy recommendation unchanged. Brewin Dolphin Holdi

Read more
19 Mar 2013 09:38

REFILE-Johnston Press profit falls 56 pct on lower ad revenue

March 19 (Reuters) - British regional newspaper publisher Johnston Press Plc said full-year profit more than halved on lower advertising revenue, and added that the challenging trading environment seen in the second half of 2012 had continued into the start of this year. The company, which

Read more
19 Mar 2013 07:29

Johnston Press underlying profit slumps

Media group Johnston Press reported a sharp decline in underlying profit and advertising revenues for the full year but posted a twelve per cent increase in digital advertising revenues. The heavily indebted newspaper publisher said underlining pre-tax profit tumbled to £12.6m in the 52 weeks ended

Read more
14 Dec 2012 10:37

Chief Operating Officer resigns from Johnston Press

Johnston Press has announced Chief Operating Officer Danny Cammiade will be stepping down as the media company undergoes a restructuring. Cammiade, who has been an executive director since 2005, will leave the organisation next March. Chairman of Johnston Press, Ian Russell, said: "Danny has be

Read more
13 Dec 2012 07:22

Thursday broker round-up UPDATE

Advanced Medical Solutions: Investec reduces target price from 93p to 68p and downgrades from buy to hold. Numis downgrades to hold, while maintaining the target price at 165p. Canaccord Genuity moves target price from 93p to 90p and retains a buy recommendation. Anglo American: JP Morgan moves tar

Read more
7 Dec 2012 07:04

Friday broker round-up UPDATE

Bellway: Northland Capital raises target price from 1050p to 1150p and keeps a buy rating. Panmure Gordon raises target price from 957p to 1013p, while maintaining a hold recommendation. Berkeley Group: Panmure Gordon raises target price from 1390p to 1650p keeping a hold rating. Booker Group: Gol

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.